BAXALTA INC |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2016 | Baxalta : Shire jumps as Vyvanse drug helps it to beat earnings forecast | RE |
| 2016 | Baxalta : Shire director pay resolution just scrapes though at general meet | RE |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 696,900,477 | 683,370,768 ( 98.06 %) | 0 | 98.06 % |
Company contact information
Group companies
| Name | Category and Sector |
|---|---|
Baxalta US, Inc.
 Baxalta US, Inc. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Baxalta US, Inc. engages in the research, development, and manufacture of biopharmaceutical products. The private company is based in Deerfield, IL. |
Biotechnology
|
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -16.09% | 15.35B | |
| -9.14% | 11.95B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| +5.24% | 8.71B |
- Stock Market
- Equities
- Stock
- Company Baxalta Inc
